Plasma copeptin concentration is a predictor of tolvaptan efficacy in patients with hepatic ascites

Abstract Aims No solid evidence‐based opinion was raised regarding predictors of the degree of ascites reduction with tolvaptan. This retrospective cohort study aimed to examine whether serum copeptin concentration is a useful predictor of this. Methods The study population consisted of 80 patients...

全面介紹

書目詳細資料

發表在:	Portal Hypertension & Cirrhosis
Main Authors:	Fumimasa Tomooka, Kei Moriya, Takahiro Kubo, Akihiko Shibamoto, Jyunya Suzuki, Satoshi Iwai, Soichi Takeda, Yuki Fujimoto, Masahide Enomoto, Koji Murata, Yuki Tsuji, Yukihisa Fujinaga, Koh Kitagawa, Norihisa Nishimura, Hiroaki Takaya, Kosuke Kaji, Hideto Kawaratani, Tadashi Namisaki, Takemi Akahane, Akira Mitoro, Hitoshi Yoshiji
格式:	Article
語言:	英语
出版:	Wiley 2023-09-01
主題:	ascites copeptin decompensated liver cirrhosis diuretics tolvaptan
在線閱讀:	https://doi.org/10.1002/poh2.55